title: Serum cholesterol and risk of Alzheimer disease: a community-based cohort study.
abstract: OBJECTIVE
  To examine the association of serum total cholesterol (TC) and high density lipoprotein (HDL) levels and subsequent incidence of dementia and Alzheimer disease (AD) in a population-based cohort study.
  
  
  METHODS
  A cohort of cognitively intact persons, aged 65 and older, was randomly selected from Group Health Cooperative (GHC), a large health maintenance organization, and was assessed biennially for dementia. Premorbid levels of TC and HDL were obtained from a computerized clinical laboratory database at GHC. Cox proportional hazards regression was used to calculate hazard ratios (HR, 95% CI) for dementia and AD associated with quartiles of TC and HDL levels.
  
  
  RESULTS
  Of the 2,356 eligible participants, 2,141 had at least one serum TC measure prior to the initial enrollment. Using the lowest TC quartiles as the reference group, the HR in the highest TC quartiles was not significantly elevated for dementia (1.16, 0.81 to 1.67) or for AD (1.00, 0.61 to 1.62) after adjusting for age, sex, education, baseline cognition, vascular comorbidities, body mass index, and lipid-lowering agent use. Serum HDL showed a similar lack of significant association with risk of dementia or AD. Models that included the presence of one or more APOE-epsilon4 alleles showed a typical association of epsilon4 with AD risk. This association was not materially modified by inclusion of TC level.
  
  
  CONCLUSIONS
  The data do not support an association between serum total cholesterol or high density lipoprotein in late life and subsequent risk of dementia or Alzheimer disease (AD). The increased risk of AD with APOE-epsilon4 is probably not mediated by serum total cholesterol levels.
authors.affiliation: Department of Psychiatry and Behavioral Science, University of Washington, Seattle, WA, USA. gli@u.washington.edu
authors.forename: G
authors.initials: G
authors.lastname: Li
authors.forename: J B
authors.initials: JB
authors.lastname: Shofer
authors.forename: W A
authors.initials: WA
authors.lastname: Kukull
authors.forename: E R
authors.initials: ER
authors.lastname: Peskind
authors.forename: D W
authors.initials: DW
authors.lastname: Tsuang
authors.forename: J C S
authors.initials: JC
authors.lastname: Breitner
authors.forename: W
authors.initials: W
authors.lastname: McCormick
authors.forename: J D
authors.initials: JD
authors.lastname: Bowen
authors.forename: L
authors.initials: L
authors.lastname: Teri
authors.forename: G D
authors.initials: GD
authors.lastname: Schellenberg
authors.forename: E B
authors.initials: EB
authors.lastname: Larson
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000097:blood* / Q000453:epidemiology* / Q000503:physiopathology; D015984:Causality; D002784:Cholesterol / Q000097:blood*; D008076:Cholesterol, HDL / Q000097:blood; D015331:Cohort Studies; D003324:Coronary Artery Disease / Q000453:epidemiology; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood* / Q000453:epidemiology* / Q000503:physiopathology; D006973:Hypertension / Q000453:epidemiology; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008297:Male; D011446:Prospective Studies; D012307:Risk Factors; D012737:Sex Factors; D014861:Washington / Q000453:epidemiology
chemical_list: D008076:Cholesterol, HDL; D000960:Hypolipidemic Agents; D002784:Cholesterol